TRDA
Entrada Therapeutics, Inc. · Healthcare
Director Kush Parmar sold $1.1M of Entrada Therapeutics, Inc.
Sold$1,078,937
$6.95Price
155,255Shares
−5%Stake
What TRDA did after the filing
- The stock from Tue, Aug 11 open, $7.00
- −11.1%
- S&P 500, same days
- −0.9%
Measured over 30 trading days, to the Sep 24 close.
Traded Thu, Aug 6. Filed Mon, Aug 10, 7:54 PM ET, after the close. Returns use the Aug 11 open and the Sep 24 close. Not investment advice.